The High Speed Cell Sorter Core (HSCS Core) provides the following services: 1. Cell sorting. A three laser, high speed cell sorter (MoFIo, DakoCytomation, Inc.) with a flexible configuration is housed in the HSCS laboratory. Dedicated technicians in the Core are responsible for all aspects of instrument operation. 2. Flow cytometric analysis. A three-color benchtop analytical instrument (BD FACScan) is available in the HSCS Core laboratory for self-service or supervised use by SCC members. 3. Sample preparation. For investigators lacking suitable infrastructure to prepare samples for flow cytometric analysis, the HSCS Core provides a range of technical assistance from experimental design to cell isolation, staining, and analysis. Flow cytometry is a powerful tool widely utilized in clinical oncology and cancer biology research. The HSCS Core was established to serve a growing number of investigators at the Washington University School of Medicine whose needs were not adequately met by existing cell sorting facilities on campus. A shared instrumentation grant from the NCRR provided funds for the purchase of a high speed cell sorter. Additional hardware and software were acquired with support from the SCC. The core is now a fully equipped state-of-the- art facility that strives to improve the quality of flow cytometry research performed in the SCC by assisting investigators in all phases of their experiments from planning to publication.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA091842-08
Application #
7674620
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
8
Fiscal Year
2008
Total Cost
$279,723
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Cherian, Mathew A; Olson, Sydney; Sundaramoorthi, Hemalatha et al. (2018) An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia. J Biol Chem 293:6844-6858
Smith, Lee; Ae Lee, Jung; Mun, Junbae et al. (2018) Levels and patterns of self-reported and objectively-measured free-living physical activity among prostate cancer survivors: A prospective cohort study. Cancer :
Burclaff, Joseph; Mills, Jason C (2018) Plasticity of differentiated cells in wound repair and tumorigenesis, part II: skin and intestine. Dis Model Mech 11:
Ekenga, Christine C; Pérez, Maria; Margenthaler, Julie A et al. (2018) Early-stage breast cancer and employment participation after 2 years of follow-up: A comparison with age-matched controls. Cancer 124:2026-2035
Lin, Huawen; Guo, Suyang; Dutcher, Susan K (2018) RPGRIP1L helps to establish the ciliary gate for entry of proteins. J Cell Sci 131:
Parikh, Rajiv P; Myckatyn, Terence M (2018) Paravertebral blocks and enhanced recovery after surgery protocols in breast reconstructive surgery: patient selection and perspectives. J Pain Res 11:1567-1581
Duan, Chong; Kallehauge, Jesper F; Pérez-Torres, Carlos J et al. (2018) Modeling Dynamic Contrast-Enhanced MRI Data with a Constrained Local AIF. Mol Imaging Biol 20:150-159
Zigler, Rachel E; Madden, Tessa; Ashby, Caitlin et al. (2018) Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled Trial. Obstet Gynecol 132:888-894
Murali, Bhavna; Ren, Qihao; Luo, Xianmin et al. (2018) Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss. Cancer Res 78:5618-5630
Ahmad, Fahd A; Jeffe, Donna B; Plax, Katie et al. (2018) Characteristics of youth agreeing to electronic sexually transmitted infection risk assessment in the emergency department. Emerg Med J 35:46-51

Showing the most recent 10 out of 1244 publications